文献速递复苏、休克与脓毒症消化、代谢与肾脏急症

急诊科脓毒症凝血相关生物标志物的诊断潜力:一项初步观察性队列研究方案

Diagnostic Potential of Coagulation-Related Biomarkers for Sepsis in the Emergency Department: Protocol for a Pilot Observational Cohort Study.
PubMed 文献 · Crit Care Explor · 2021-04-26
一句话结论研究方案拟纳入250例疑似脓毒症患者,评估凝血与炎症生物标志物单用或联合标准生化检测诊断急诊成人脓毒症的准确性。

75%至80%的脓毒症患者经急诊科入院,早期诊断对改变预后重要,但目前缺乏可靠生物标志物。本研究为前瞻性观察性队列研究,目标纳入加拿大两个急诊科的250例疑似脓毒症患者,在初始就诊和4小时后两个时间点采血,按Sepsis-3定义将患者判定为脓毒症、感染或非感染。将用C统计量确定各生物标志物区分脓毒症与非脓毒症的最佳截断值及敏感度和特异度,并用逐步多元逻辑回归建立生物标志物组合。研究旨在确定早期凝血异常对脓毒症诊断的潜在价值。

要点

  • 目标纳入加拿大两个急诊科的250例疑似脓毒症患者,急诊医师负责入组。
  • 血样在初始就诊和4小时后两个时间点采集,按Sepsis-3定义判定脓毒症、感染或非感染状态。
  • 用C统计量确定各生物标志物区分脓毒症与非脓毒症的最佳截断值、敏感度和特异度。
  • 用逐步多元逻辑回归(剔除不显著协变量)建立生物标志物组合。
  • 研究聚焦凝血相关生物标志物联合炎症标志物及标准生化检测对急诊成人脓毒症的早期诊断准确性。

适用人群与场景

  • 加拿大两个急诊科中由急诊医师入组的疑似脓毒症成人患者,目标样本量250例。

诊断标准与关键阈值

  • 按Sepsis-3定义将患者判定为脓毒症、感染或非感染状态。

处置流程与药物剂量

  • 在初始就诊和4小时后两个时间点采集血样。
  • 用C统计量确定各生物标志物区分脓毒症与非脓毒症的最佳截断值及敏感度和特异度。
  • 用逐步多元逻辑回归分析,剔除不显著协变量后建立生物标志物组合。

研究设计与关键结果

  • 研究方案:前瞻性观察性队列研究,目标纳入加拿大两个急诊科的250例疑似脓毒症患者,在初始就诊和4小时后采血,按Sepsis-3定义判定脓毒症、感染或非感染状态。
  • 将用C统计量确定各生物标志物区分脓毒症与非脓毒症的最佳截断值及敏感度和特异度,并用逐步多元逻辑回归建立生物标志物组合。

证据类型、等级与局限

  • 证据类型:前瞻性观察性队列研究方案。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Between 75% and 80% of patients with sepsis arrive in the hospital through the emergency department. Early diagnosis is important to alter patient prognosis, but currently, there is no reliable biomarker. The innate immune response links inflammation and coagulation. Several coagulation -related biomarkers are associated with poor prognosis in the ICU. The role of coagulation biomarkers to aid in early sepsis diagnosis has not previously been investigated. The objective of our study is to determine the individual or combined accuracy of coagulation and inflammation biomarkers with standard biochemical tests to diagnose adult septic patients presenting to the emergency department.

METHODS: in the Emergency Department is a prospective, observational cohort study with a target enrolment of 250 suspected septic patients from two Canadian emergency departments. The emergency physicians will enroll patients with suspected sepsis. Blood samples will be collected at two time points (initial presentation and 4 hr following). Patients will be adjudicated into septic, infected, or not infected status in accordance with the Sepsis-3 definitions. Patient demographics, cultures, diagnosis, and biomarkers will be reported using descriptive statistics. Optimal cut off values with sensitivity and specificity for each biomarker will be determined using C-statistics to distinguish between septic and nonseptic patients. Stepwise multiple logistic regression analysis with exclusion of nonsignificant covariates from the final model will be used to establish a panel of biomarkers.

CONCLUSIONS: Our protocol describes the processes and methods for a pragmatic observational biomarker study in the emergency department. This study will seek to determine the potential diagnostic importance of early coagulation abnormalities to identify additional tools for sepsis diagnosis.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Arora J, Klowak JA, Parpia S, et al. Diagnostic Potential of Coagulation-Related Biomarkers for Sepsis in the Emergency Department: Protocol for a Pilot Observational Cohort Study. Crit Care Explor. 2021. PMID: 33928260. doi:10.1097/CCE.0000000000000414

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。